Ubiquitin‐dependent regulation of MYC: A promising therapeutic target

Ubiquitin‐dependent regulation of MYC: A promising therapeutic target

Bibliographic Details
Main Authors:	Bryony G. Kennedy, Jonathan J. Morgan, Lisa J. Crawford
Format:	Article
Language:	English
Published:	Wiley 2023-04-01
Series:	Clinical and Translational Discovery
Subjects:	E3 ligase MYC TRIP12 ubiqutin
Online Access:	https://doi.org/10.1002/ctd2.190

Similar Items

Ubiquitination and the Proteasome as Drug Targets in Trypanosomatid Diseases
by: Marie-José Bijlmakers
Published: (2021-01-01)

E3 Ubiquitin Ligase TRIP12: Regulation, Structure, and Physiopathological Functions
by: Manon Brunet, et al.
Published: (2020-11-01)

How Many Faces Does the Plant U-Box E3 Ligase Have?
by: Xinguo Mao, et al.
Published: (2022-02-01)

Ubiquitylation of unphosphorylated c-myc by novel E3 ligase SCFFbxl8
by: Sagar Bajpai, et al.
Published: (2022-12-01)

Epigenetic modification in the expression of p73 p73 - epigenetic target for anticancer therapy
by: Faiza Naseer, et al.
Published: (2019-07-01)

The E3 ubiquitin ligase HUWE1 acts through the N‐Myc‐DLL1‐NOTCH1 signaling axis to suppress glioblastoma progression
by: Ye Yuan, et al.
Published: (2022-09-01)

The Ubiquitin System and Jasmonate Signaling
by: Astrid Nagels Durand, et al.
Published: (2016-01-01)

Review: proteins c-Myc and Myc-nick as potential targets for the melignant melanoma treatment
by: G. Maryniuk, et al.
Published: (2023-07-01)

MYC function and regulation in physiological perspective
by: Rajiv Kumar Jha, et al.
Published: (2023-10-01)

Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13
by: Mei Zeng, et al.
Published: (2018-11-01)

Wogonin Attenuates Isoprenaline-Induced Myocardial Hypertrophy in Mice by Suppressing the PI3K/Akt Pathway
by: Weichun Qian, et al.
Published: (2018-08-01)

MYC Immunohistochemistry Predicts MYC Rearrangements by FISH
by: Julum Nwanze, et al.
Published: (2017-09-01)

The Molecular ‘Myc-anisms’ behind Myc-Driven Tumorigenesis and the Relevant Myc-Directed Therapeutics
by: Jessica McAnulty, et al.
Published: (2020-12-01)

Role of the Mitochondrial E3 Ubiquitin Ligases as Possible Therapeutic Targets in Cancer Therapy
by: Jacopo Di Gregorio, et al.
Published: (2023-12-01)

m6A-modified circARHGAP12 promotes the aerobic glycolysis of doxorubicin-resistance osteosarcoma by targeting c-Myc
by: Dawei Zhang, et al.
Published: (2024-01-01)

Gene Transactivation and Transrepression in MYC-Driven Cancers
by: Marika Scafuro, et al.
Published: (2021-03-01)

PRMT5 as a Potential Therapeutic Target in MYC-Amplified Medulloblastoma
by: Devendra Kumar, et al.
Published: (2023-12-01)

Targeting MYC through WDR5
by: Lance R. Thomas, et al.
Published: (2020-03-01)

Targeting c-MYC: a potential non-hormonal therapeutic approach for endometriosis treatment
by: Warren B. Nothnick, et al.
Published: (2023-11-01)

Spotlight on New Therapeutic Opportunities for MYC-Driven Cancers
by: D'Avola A, et al.
Published: (2023-06-01)

Rewired Metabolism Caused by the Oncogenic Deregulation of MYC as an Attractive Therapeutic Target in Cancers
by: Laura Vízkeleti, et al.
Published: (2023-06-01)

The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer
by: Jun-O Jin, et al.
Published: (2021-09-01)

The Myc Road to Hearing Restoration
by: Bernd Fritzsch, et al.
Published: (2012-09-01)

Small molecule Z363 co‐regulates TAF10 and MYC via the E3 ligase TRIP12 to suppress tumour growth
by: Yan Xiong, et al.
Published: (2023-01-01)

Hyperoxia Inhibits Proliferation of Retinal Endothelial Cells in a Myc-Dependent Manner
by: Charandeep Singh, et al.
Published: (2021-06-01)

Targeting MYC at the intersection between cancer metabolism and oncoimmunology
by: Simran Venkatraman, et al.
Published: (2024-02-01)

Blocking Myc to Treat Cancer: Reflecting on Two Decades of Omomyc
by: Daniel Massó-Vallés, et al.
Published: (2020-04-01)

E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma
by: Kristina Bielskienė, et al.
Published: (2015-01-01)

Myc-Related Mitochondrial Activity as a Novel Target for Multiple Myeloma
by: Alejandra Ortiz-Ruiz, et al.
Published: (2021-04-01)

Rationale for MYC imaging and targeting in pancreatic cancer
by: Günter Schneider, et al.
Published: (2021-10-01)

A Nucleolar Isoform of the Drosophila Ubiquitin Specific Protease dUSP36 Regulates MYC-Dependent Cell Growth
by: Dominique Thevenon, et al.
Published: (2020-06-01)

Targeted Downregulation of MYC through G-quadruplex Stabilization by DNAi
by: Alexandra Maria Psaras, et al.
Published: (2021-09-01)

“Double-Hit” Chronic Lymphocytic Leukemia, Involving the TP53 and MYC Genes
by: Florence Nguyen-Khac, et al.
Published: (2022-01-01)

HRas and Myc synergistically induce cell cycle progression and apoptosis of murine cardiomyocytes
by: Aleksandra Boikova, et al.
Published: (2022-10-01)

Investigating In Situ Expression of c-MYC and Candidate Ubiquitin-Specific Proteases in DLBCL and Assessment for Peptidyl Disruptor Molecule against c-MYC-USP37 Complex
by: Durr e Sameen Kamran, et al.
Published: (2023-03-01)

Tumor cell‐specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase
by: Stefanie Peter, et al.
Published: (2014-12-01)

Knockdown of ubiquitin‐specific peptidase 13 inhibits cell growth of hepatocellular carcinoma by reducing c‐Myc expression
by: Jing Huang, et al.
Published: (2020-08-01)

In silico modeling of phosphorylation dependent and independent c-Myc degradation
by: Debangana Chakravorty, et al.
Published: (2019-05-01)

Elevating SOX2 Downregulates MYC through a SOX2:MYC Signaling Axis and Induces a Slowly Cycling Proliferative State in Human Tumor Cells
by: Ethan P. Metz, et al.
Published: (2022-04-01)

STK16 promoted colorectal cancer progress in a c-MYC signaling-dependent manner
by: Li Peng, et al.
Published: (2024-04-01)